Inito Secures Multi-Million Dollar Seed Funding to Advance At-Home Lab-Grade Fertility Diagnostic Device

VCBeat (WeChat ID: vcbeat) recently learned that Inito, an Indian smart medical device company, has announced the completion of a seed funding round amounting to several million U.S. dollars, becoming the first Indian medical device startup backed by the Silicon Valley venture capital firm Y Combinator. This venture capital firm has invested in numerous well-known startups, such as Airbnb, Reddit, Quora, and Dropbox.

Inito, headquartered in Bangalore, India, was founded in 2014 by Ayush Rai and Dr. Varun AV, focusing on the development of compact smart medical devices. By connecting to smartphones, these devices enable customers to test various health conditions at home, such as diabetes, cholesterol levels, hormones, and vitamin levels. The mobile app analyzes and tracks data, helping users manage their health without frequent hospital visits. These devices are not only accurate and reliable but also portable and easy to use.

Inito’s flagship product, the Inito Fertility Monitor, has received three prestigious awards: the CII Design Award, India’s Design Mark Award, and Japan’s G-Mark Design Award.

Inito Fertility Monitor is a compact device designed for laboratory-grade fertility diagnostic testing at home. The device comes with a display, test strips, and a mobile app, leveraging the company’s proprietary “planar lens” technology, which is currently patent-pending.

Inito Fertility Monitor is priced at approximately ¥292 (Source: Inito Official Website)

The Inito Fertility Monitor measures estrogen and luteinizing hormone levels in urine, enabling women to accurately identify their ovulation window at home and increase their chances of conception to 89%. The companion app records each user’s cycle variations and provides highly accurate measurement results.

Inito now plans to add eight hormone tests to its device. This will help track several key indicators of user fertility, enabling the diagnosis of reproductive potential without the need for hospital visits. The company aims to disrupt the traditional $30 billion fertility market. To date, the device has collected over 50,000 test results. By leveraging big data analytics and artificial intelligence, Inito will be able to provide more accurate fertility predictions for future users.

Discussing the support from Y Combinator, Ayush Rai, co-founder of Inito, stated: “Inito’s goal is to establish a diagnostic laboratory in every household, enabling personalized medical diagnostics for everyone. Y Combinator has provided us with financial support, allowing us to think globally and fulfill our mission.”

Y Combinator is a startup incubator located in Silicon Valley, USA, founded in 2005. The firm pioneered a new investment model, providing small amounts of capital ($120,000 per company) to a large cohort of startups (most recently, 68 companies) twice a year. Selected companies relocate to Silicon Valley for a three-month program. Y Combinator partners work closely with each company to help them grow rapidly, culminating in a demo day where the startups present their products and services to investors and the media. To date, Y Combinator has invested in a total of 2,179 companies.

(Compiled by: Yang Shaobo)